Akari Therapeutics News

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 4 16:34 ET

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 1 17:32 ET

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 11 17:28 ET

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 5 17:01 ET

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 5 08:37 ET

Akari Therapeutics | 424B3: Prospectus

Oct 27, 2023 16:15 ET

Akari Therapeutics | EFFECT: Others

Oct 27, 2023 00:15 ET

Akari Therapeutics | EFFECT: Others

Oct 24, 2023 00:15 ET

Akari Therapeutics | EFFECT: Others

Oct 24, 2023 00:15 ET

Akari Therapeutics | EFFECT: Others

Jun 7, 2023 00:15 ET

Akari Therapeutics | EFFECT: Others

Jun 7, 2023 00:15 ET

Akari Therapeutics | 424B5: Prospectus

Mar 31, 2023 10:29 ET

Akari Therapeutics | 424B3: Prospectus

Nov 9, 2022 16:11 ET

Akari Therapeutics | EFFECT: Others

Nov 9, 2022 00:15 ET

Akari Therapeutics | 424B5: Prospectus

Sep 14, 2022 12:19 ET

Akari Therapeutics | 424B5: Prospectus

Mar 9, 2022 21:39 ET

Akari Therapeutics | 424B5: Prospectus

Jan 3, 2022 21:41 ET

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 00:15 ET

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 00:15 ET

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 00:15 ET